Movement Alert｜BrainNow Medical-B Rises 8.33% in Regular Trading, Brain-Computer Interface Sector Catalyst Drives Concept Rebound

Market Focus06-05

On June 5, BrainNow Medical-B rose 8.33% in regular trading, trading at HKD 2.64 per share, with trading volume of approximately HKD 94.47 million.

On the news front, the brain-computer interface (BCI) industry has seen a series of positive developments recently. China's first invasive BCI medical device registration certificate has been approved for market launch, accelerating the industry's commercialization pathway, with capital intensively investing in leading projects. BrainNow Medical, as a cognitive disorder digital therapeutics company combining brain science with AI technology, is viewed by the market as a BCI concept-linked stock.

Notably, the stock had previously declined sharply to historic lows following shareholder disposals and discounted block trades. On May 15, a shareholder sold 36 million shares at HKD 3.22, followed by pre-market block transactions at significant discounts to closing prices on May 20 and subsequent sessions. The current rebound may therefore also carry characteristics of an oversold recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1127870656?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 10:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127870656","market":"us","top_or_hot":-1,"title":"Movement Alert｜BrainNow Medical-B Rises 8.33% in Regular Trading, Brain-Computer Interface Sector Catalyst Drives Concept Rebound","media":"Market Focus","content":"<p><p>On June 5, BrainNow Medical-B rose 8.33% in regular trading, trading at HKD 2.64 per share, with trading volume of approximately HKD 94.47 million.</p><p>On the news front, the brain-computer interface (BCI) industry has seen a series of positive developments recently. China's first invasive BCI medical device registration certificate has been approved for market launch, accelerating the industry's commercialization pathway, with capital intensively investing in leading projects. BrainNow Medical, as a cognitive disorder digital therapeutics company combining brain science with AI technology, is viewed by the market as a BCI concept-linked stock.</p><p>Notably, the stock had previously declined sharply to historic lows following shareholder disposals and discounted block trades. On May 15, a shareholder sold 36 million shares at HKD 3.22, followed by pre-market block transactions at significant discounts to closing prices on May 20 and subsequent sessions. The current rebound may therefore also carry characteristics of an oversold recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BrainNow Medical-B Rises 8.33% in Regular Trading, Brain-Computer Interface Sector Catalyst Drives Concept Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BrainNow Medical-B Rises 8.33% in Regular Trading, Brain-Computer Interface Sector Catalyst Drives Concept Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-05 10:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 5, BrainNow Medical-B rose 8.33% in regular trading, trading at HKD 2.64 per share, with trading volume of approximately HKD 94.47 million.</p><p>On the news front, the brain-computer interface (BCI) industry has seen a series of positive developments recently. China's first invasive BCI medical device registration certificate has been approved for market launch, accelerating the industry's commercialization pathway, with capital intensively investing in leading projects. BrainNow Medical, as a cognitive disorder digital therapeutics company combining brain science with AI technology, is viewed by the market as a BCI concept-linked stock.</p><p>Notably, the stock had previously declined sharply to historic lows following shareholder disposals and discounted block trades. On May 15, a shareholder sold 36 million shares at HKD 3.22, followed by pre-market block transactions at significant discounts to closing prices on May 20 and subsequent sessions. The current rebound may therefore also carry characteristics of an oversold recovery.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06681","symbol_name":"脑动极光-B","start_time":0,"source_url":"","article_id":"1127870656","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127870656","pubTimestamp":1780625097,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 5, BrainNow Medical-B rose 8.33% in regular trading, trading at HKD 2.64 per share, with trading volume of approximately HKD 94.47 million.On the news front, the brain-computer interface...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06681":"脑动极光-B"},"translate_title":"动向提示|BrainNow医疗-B常规交易涨8.33%脑机接口板块催化剂带动概念反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06681":1},"content_text":"On June 5, BrainNow Medical-B rose 8.33% in regular trading, trading at HKD 2.64 per share, with trading volume of approximately HKD 94.47 million.On the news front, the brain-computer interface (BCI) industry has seen a series of positive developments recently. China's first invasive BCI medical device registration certificate has been approved for market launch, accelerating the industry's commercialization pathway, with capital intensively investing in leading projects. BrainNow Medical, as a cognitive disorder digital therapeutics company combining brain science with AI technology, is viewed by the market as a BCI concept-linked stock.Notably, the stock had previously declined sharply to historic lows following shareholder disposals and discounted block trades. On May 15, a shareholder sold 36 million shares at HKD 3.22, followed by pre-market block transactions at significant discounts to closing prices on May 20 and subsequent sessions. The current rebound may therefore also carry characteristics of an oversold recovery.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1127870656","isCrawlerRequest":true}